Your browser doesn't support javascript.
loading
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials.
Agyeman, Akosua A; You, Tao; Chan, Phylinda L S; Lonsdale, Dagan O; Hadjichrysanthou, Christoforos; Mahungu, Tabitha; Wey, Emmanuel Q; Lowe, David M; Lipman, Marc C I; Breuer, Judy; Kloprogge, Frank; Standing, Joseph F.
Affiliation
  • Agyeman AA; Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London, UK.
  • You T; Beyond Consulting Ltd., Cheshire, UK.
  • Chan PLS; Medical Research Council, UK.
  • Lonsdale DO; Pfizer, Sandwich, Kent, UK.
  • Hadjichrysanthou C; Department of Clinical Pharmacology, St George's University of London, London, UK.
  • Mahungu T; Department of Intensive Care, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Wey EQ; Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
  • Lowe DM; Department of Infectious Diseases, Royal Free Hospital London NHS Foundation Trust, London, UK.
  • Lipman MCI; Department of Infectious Diseases, Royal Free Hospital London NHS Foundation Trust, London, UK.
  • Breuer J; Centre for Clinical Microbiology, Division of Infection and Immunity University College London, London, UK.
  • Kloprogge F; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK.
  • Standing JF; Institute of Immunity and Transplantation, University College London, Royal Free Campus, London, UK.
Br J Clin Pharmacol ; 88(12): 5428-5433, 2022 12.
Article in En | MEDLINE | ID: mdl-36040430
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article